Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PMVPPMVP
Showing 8 of 24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PMV PHARMACEUTICALS INC

Yes. Citadel Advisors holds 47,308 shares of PMVP (PMV Pharmaceuticals), worth $63,393, as of its Q2 2026 13F filing. It increased the position by 2,260 shares (+5.0%) from Q1 2026. Citadel Advisors has held PMVP in every 13F on record since Q3 2020, 24 quarterly filings.

Current Value

$63,393

Current Shares

47,308

Total Value Change

-$1.5M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
47,308
+5.0%
$63,3930.0%$1.34
15
2026-Q1
Decreased
45,048
-62.0%
$55,8600.0%$1.62
0
2025-Q4
Decreased
118,593
-38.6%
$148,2410.0%$1.22
0
2025-Q3
Decreased
193,153
-24.7%
$270,4140.0%$1.45
0
2025-Q2
Increased
256,431
+1716.1%
$271,8170.0%$1.07
26
2025-Q1
Decreased
14,120
-86.9%
$15,3910.0%$1.11
0
2024-Q4
Decreased
107,888
-89.8%
$162,9110.0%$1.49
0
2024-Q3
Decreased
1.1M
-38.5%
$1.6M0.0%$1.50
0

Other major holders of PMVP: VIKING GLOBAL INVESTORS LP, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used